1Kim J M,Kim J S,Jung H C,et al.Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul,South Korea[J].Antimicrob Agents Chemother,2004,48:4843.
2Davis R,Bryson H M.Levofloxacin.A review of its antibacterial activity,pharmacokinetics and therapeutic efficacy[J].Drugs,1994,47:677.
4Van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Theatment of Helicobacter pylori infection: a review of the world literature. Helicobacter, 1996,1:6-19.
5Georgopoulos SD, Ladas SD, Karatapanis S, et al. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci,2000 ,45:63-67.
6Piccolomini R, Bonaventura G, Catamo G, et al. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol,1997,35:1842-1844.
7Pfaller MA, Barry AL, Fuchs PC, et al. Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests. J Clin Microbiol,1993, 31:1924-1926.
8Sharma VK, Vasudeva R, Howden CW. A national survey of gastroenterologists' current opinions and practices related to Hp. Am J Gastroenterol,1998,93:1647-1657.
9Franzin L, Pennazio M, Cabodi D, et al. Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol, 2000,40:96-100.
10Ducons JA, Santolaria S, Guirao R, et al. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a porospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther, 1999,13:775-780.
